Search

everythinglearnresearchcommunity

for

Search:↓

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

CTCF protein is essential for skin and hair follicle development in mice.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

The study improved understanding of gene roles in cashmere goat hair growth, aiding future cashmere production.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

The combined treatments were highly effective for improving atrophic acne scars.

More research is needed to make sperm DNA fragmentation a reliable tool for diagnosing male infertility.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

JAK inhibitors partially restore scalp bacteria balance in alopecia areata patients.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

New techniques improve understanding of cell cycle dynamics at the single-cell level.

Transglutaminases work through a ping-pong mechanism, and human plasma and platelet transglutaminases have similar catalytic subunits.

The study identified a key protein involved in producing underarm odor and found ways to inhibit it.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

New mutations in the hairless gene may cause hair loss and affect bone development.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.